Related references
Note: Only part of the references are listed.Altered Proliferation and Differentiation Properties of Primary Mammary Epithelial Cells from BRCA1 Mutation Carriers
Laura N. Burga et al.
CANCER RESEARCH (2009)
Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers
Patricia A. Shaw et al.
MODERN PATHOLOGY (2009)
Risk factors for a serous cancer precursor (p53 signature) in women with inherited BRCA mutations
Aasia Saleemuddin et al.
GYNECOLOGIC ONCOLOGY (2008)
A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
Ann K. Folkins et al.
GYNECOLOGIC ONCOLOGY (2008)
Primary Fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction
Michael J. Callahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship
David W. Kindelberger et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
The distal fallopian tube: a new model for pelvic serous carcinogenesis
Christopher P. Crum et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2007)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations
Kathy Qi Cai et al.
GYNECOLOGIC ONCOLOGY (2006)
Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions -: Report of 6 cases and review of the literature
Maria L. Carcangiu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy
Julie D. Lamb et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27Kip1
EA Williamson et al.
ONCOGENE (2006)
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome
F Medeiros et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers
A Finch et al.
GYNECOLOGIC ONCOLOGY (2006)
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
T Pal et al.
CANCER (2005)
Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers
J Palacios et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: Role of serial sectioning in the detection of occult malignancy
CB Powell et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis -: A mutational analysis with immunohistochemical correlation
G Singer et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
EM Swisher et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations
SN Agoff et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition
JMJ Piek et al.
HISTOPATHOLOGY (2003)
A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors
LM Kmet et al.
CANCER (2003)
Pathologic findings in prophylactic oophorectomy specimens in high-risk women
K Leeper et al.
GYNECOLOGIC ONCOLOGY (2002)
BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1
EA Williamson et al.
ONCOGENE (2002)
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
JMJ Piek et al.
JOURNAL OF PATHOLOGY (2001)
Occult carcinoma in prophylactic oophorectomy specimens - Prevalence and association with BRCA germline mutation status
TJ Colgan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
HA Risch et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Germline BRCA1/2 mutations and p27Kip1 protein levels independently predict outcome after breast cancer
PO Chappuis et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
